This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Apple, RIM, PNC, IBM: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Apple (AAPL - Get Report) estimates, target lowered at Oppenheimer. AAPL estimates were cut through 2012. Visibility remains poor on the next iPhone launch. Outperform rating and new $420 price target.

Apple (AAPL - Get Report) rated new Outperform at FBN Securities. $500 price target. Company is a leader in fast-growing markets.

Alkermes (ALKS - Get Report) rated new Buy at MKM Partners. $20 price target. ELN deal should help add to growth.

Aruba Networks (ARUN - Get Report) rated new Outperform at Morgan Keegan. $35 price target. Company is leveraged to higher demand for a distributed workforce.

Biogen Idec (BIIB) upgraded at Deutsche Bank from Hold to Buy. $129 price target. Large cap biotech stock with significant opportunity for upside.

Salesforce.com (CRM) rated new Neutral at JP Morgan. Shares are fairly valued given recent operating spend. $140 price target.

Dell (DELL) rated new Outperform at FBN Securities. $19 price target. Company has solid exposure to enterprise market.

Hewlett-Packard (HPQ) rated new Sector Perform at FBN Securities. $38 price target. Company's execution has been poor in recent quarters.

IBM (IBM) rated new Outperform at FBN Securities. $200 price target. Company can continue to deliver consistent growth over the next few years.

McDermott (MDR) rated new Buy at Goldman. Company was also added to the Conviction List. $26 price target. Company has pure exposure to offshore energy growth.

Motorola Mobility (MMI) downgraded at Credit Suisse from Outperform to Underperform. $19 price target. Estimates also cut, as the company is facing increased competition.

Progressive (PGR) upgraded at Ticonderoga from Neutral to Buy, Ticonderoga said. $24 price target. Company is a market leader and deserves a premium valuation.

PNC Financial (PNC) downgraded at KBW from Outperform to Market Perform. $67 price target. RBC acquisition adds integration risk to the story.

Research in Motion (RIMM) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $30 price target. Estimates also cut, as the company has been slow to innovate its smartphone offerings.



More to come

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $132.77 1.90%
ALKS $61.82 -0.71%
ARUN $24.65 0.16%
FB $82.66 1.40%
GOOG $562.99 -0.37%

Markets

DOW 18,147.33 +67.19 0.37%
S&P 500 2,125.03 +7.34 0.35%
NASDAQ 5,115.09 +23.0050 0.45%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs